Meeder Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-22
| Closed | -$7K | – | 2465 |
|
|
2019
Q3 | $7K | Buy |
22
+15
| +214% | +$4.77K | ﹤0.01% | 1672 |
|
|
2019
Q2 | $7K | Hold |
7
| – | – | ﹤0.01% | 1583 |
|
|
2019
Q1 | $12K | Sell |
7
-93
| -93% | -$159K | ﹤0.01% | 1207 |
|
|
2018
Q4 | $188K | Buy |
100
+26
| +35% | +$48.9K | 0.02% | 512 |
|
|
2018
Q3 | $176K | Buy |
74
+67
| +957% | +$159K | 0.01% | 520 |
|
|
2018
Q2 | $25.6K | Sell |
7
-3
| -30% | -$11K | ﹤0.01% | 909 |
|
|
2018
Q1 | $29K | Sell |
10
-5
| -33% | -$14.5K | ﹤0.01% | 797 |
|
|
2017
Q4 | $40K | Buy |
15
+8
| +114% | +$21.3K | ﹤0.01% | 741 |
|
|
2017
Q3 | $19K | Hold |
7
| – | – | ﹤0.01% | 918 |
|
|
2017
Q2 | $16K | Buy |
7
+6
| +600% | +$13.7K | ﹤0.01% | 880 |
|
|
2017
Q1 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 1293 |
|
|
2016
Q3 | – | Sell |
-19
| Closed | -$58K | – | 986 |
|
|
2016
Q2 | $58K | Buy |
+19
| New | +$58K | 0.01% | 713 |
|